Skip to content

We are an innovative and ambitious med-tech company that is working tirelessly to improve the quality of life of patients suffering from a variety of Vertebral Fractures

Our Story​

Amber implants is a VC-backed MedTech start-up started its operation in 2019.

The founders of the company, Dr. Banafsheh Sajadi and Dr. Mohammad Ahmadi, have accomplished their Ph.D. degree in Delft University of Technology and started developing the innovative and creative orthopedic implants since then. The company is now consisting of a (rapidly expanding) young and ambitious team that works on the developments of the orthopedic products. Also, a well-experienced and internationally-known team are already planning for commercialization of the product in the next stage. The company is working according to ISO 13485 and FDA guidelines for manufacturing of the medical devices.

Our first product, VCFix® spinal system is currently undergoing pre-clinical validation and will be in clinical phase from 2022.

Our mission

Quality

At Amber Implants we are dedicated to deliver high quality medical products and services to improve patients’ quality of life.

Commitment

Amber Implants is committed to and accountable for advancing diversity, equity, and inclusion in all of its forms.

Team

​At Amber Implants we prioritize to build and maintain a healthy and equally treated organization with highly qualified employees.

Our team

Banafsheh
Sajadi

CO-FOUNDER, CEO​

Mohammad Ahmadi​

CO-FOUNDER, CFO​

Vincent
Gardès

EXECUTIVE CHAIRMAN​

Anne
Choi

QUALITY MANAGER​

Sanne
Aarts

PRODUCT DESIGN ENGINEER

Rossana
Schipani

CLINICAL VALIDATION SCIENTIST​

Maria Pastrama-Mastnak

CLINICAL SCIENTIST

Jonathan
Caine

PRODUCT DESIGN ENGINEER

Kaveh
Karami

SUPPLY CHAIN ENGINEER

Ehsan
Safaee

Interested in joining our team? Check our available positions or send an open application.

Research Projects

Interreg 2 Seas is an EU programme facilitating cross-border cooperation between England, France, the Netherlands and Belgium (Flanders).

Read more

Company timeline

2018
Company launch

Launching the company and recieving seed fund raising.

2019
Collaborations

Our company was involved with more than 4 European level and national level researches and collaborations with 20 research partners.

2020
VCFix® spinal system

Official kick off of the VCFix® project, including feasibility studies and receiving breakthrough designation

2021
Series A fundraising

Receiving the series A fundraising.

2022
Current status
Finishing the pre-clinical

Finishing the pre-clinical activities and  regulatory phase.

2023
Clinical

First clinical trials